World's Largest Event Focused Exclusively On the Latest Developments
in Molecular Imaging and Nuclear Medicine
June 14-18, 2008, At the Ernest N. Morial Convention Center in
New Orleans, Booth 221
KENNEWICK, Wash., June 10, 2008 (PRIME NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (Pink Sheets:ADMD) (http://www.isotopeworld.com), a company engaged in the production and distribution of medical isotopes, is hosting an exhibit at the Society of Nuclear Medicine (SNM) Annual Meeting 2008, being held at the Ernest N. Morial Convention Center in New Orleans, Louisiana, from June 14-18, 2008, booth number 221. SNM expects nearly 4,000 physicians, scientists, pharmacists, and technologists to attend the event in addition to 180 exhibiting companies.
This year's Annual Meeting aims to focus on the following issues:
* Examine and evaluate future directions in nuclear medicine and molecular imaging and therapy from a research and clinical perspective. * Describe the latest indications and applications of fusion imaging and its impact on patient management. * Review of standard, new, and relevant advances in cardiovascular imaging. * Discuss new therapeutic and diagnostic agents that are impacting the practice of nuclear medicine.
"In the world of nuclear medicine, this is the most important event of the year," said James C. Katzaroff, AMIC's President and Chairman of the Board. "We are looking forward to showcasing AMIC's compact LINAC technology to nuclear medicine experts from around the globe, and having the opportunity to illustrate the wide variety of potential products and services AMIC provides."
AMIC recently announced the initiation of production of Fluorine-18, a first in a series of isotopes that AMIC will begin manufacturing at its Kennewick, Wash. production facility. The Company also recently announced a signed Letter of Intent for the purchase of the Center of Molecular Research, based in Moscow, Russia. Established in 1993, the Center of Molecular Research (CMR) specializes in the production and sales of stable and radioactive isotopes and enjoys a broad base of clients worldwide.
About Advanced Medical Isotope Corporation
Advanced Medical Isotope Corporation (AMIC) is a medical isotope production company engaged in the production and distribution of medical isotopes and medical isotope in vivo delivery systems for advanced diagnostic and non-surgical therapeutic application. AMIC's goal is to empower physicians, medical researchers, and ultimately patients by providing them with essential medical isotopes that, until now, have not been feasible or economical, in an effort to detect and cure human disease. For more information, please visit our website, www.isotopeworld.com.
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control.